NCT00288925View on ClinicalTrials.gov

Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2007

Conditions
Pancreatic Cancer
Interventions
DRUG

Z-360

Trial Locations (1)

NW3 2QG

Royal Free Hospital, London

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY